[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Risk](https://github.com/mm80843/T3.5/tree/pages/docs/Risk/index.md) >> Individual ID:PBN__Risk_9447 

# __Identification of drugs with potential anti-coronavirus effects__

## Articles mentionning the risk

* [He_cido_2020](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_484.md)

## Mitigations of this risk

* [Conducting rigorous testing and clinical trials to confirm the safety and efficacy of identified drugs](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_11349.md)

## Name of the risk

Uncontrolled use or promotion of drugs without sufficient testing or clinical trials

## People affected by this risk

* [Healthcare providers](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_31.md)
* [Patients](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_121.md)
* [Regulatory agencies](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_401.md)

## Stakeholders who can mitigate this risk

* [Healthcare providers](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_121.md)
* [Pharmaceutical companies](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_401.md)
* [Regulatory agencies](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_124.md)

## Technologies linked to the risk

* [Clinical trial protocols](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_11183.md)
* [Laboratory testing and analysis tools](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_11184.md)

## This Risk belongs to this RiskGroup

* [Public health risks](https://github.com/mm80843/T3.5/blob/pages/RiskGroup/PBN__RiskGroup_3.md)

## This Risk belongs to this RiskSubgroup

* [Lack of effective medical solutions](https://github.com/mm80843/T3.5/blob/pages/RiskSubgroup/PBN__RiskSubgroup_37.md)

